BIOCON SOLUTIONS PVT LTD

Company Introduction:

Biocon Solutions Pvt Ltd is a subsidiary of Biocon Ltd, a prominent biopharmaceutical company headquartered in India. This entity is integral to the Biocon group, specializing in various facets of biopharmaceutical development and manufacturing. Its activities include providing contract research and manufacturing services (CRAMS), developing active pharmaceutical ingredients (APIs), and delivering comprehensive solutions across the biopharmaceutical value chain. The company utilizes advanced biotechnological expertise to support the production of biosimilars, novel biologics, and complex generic drugs.

Factory or Trader:

Biocon Solutions Pvt Ltd operates primarily as a manufacturer and a contract development and manufacturing organization (CDMO). It is directly involved in the production and development of biopharmaceutical products and related services, signifying its role as a factory or manufacturing-oriented entity with strong research and development capabilities.

Regarding Singapore:

It is important to clarify that Biocon Solutions Pvt Ltd, under this exact name, is primarily registered and operates in India. While Biocon Ltd (the parent company) and its various subsidiaries, such as Biocon Biologics, maintain a global presence and may have commercial or regional offices in Singapore (for example, Biocon Biologics Singapore Pte. Ltd.), "Biocon Solutions Pvt Ltd" itself is not directly registered as a separate company in Singapore. Any Biocon entity present in Singapore typically focuses on commercial activities, sales, marketing, and regional management rather than large-scale manufacturing facilities. Therefore, if referring to a Biocon entity in Singapore, it would generally function more as a commercial or trading office rather than a manufacturing factory.

BIOCON SOLUTIONS PVT LTD is an Indian biopharmaceutical company. Its products are sold globally, including in Singapore, through various distribution channels. The company primarily manufactures and sells products in the following categories:

Biosimilars

Insulin and Insulin Analogs: Such as Recombinant Human Insulin, Insulin Glargine, and Insulin Aspart. These are used in the management of diabetes.

Oncology products: Including biosimilar Trastuzumab, biosimilar Pegfilgrastim, and biosimilar Bevacizumab, used for various cancer treatments.

Immunology products: Such as biosimilar Adalimumab and biosimilar Etanercept, used for autoimmune diseases.

Novel Biologics

This category includes innovative biological drugs like Itolizumab, an anti-CD6 monoclonal antibody.

Biopharmaceuticals

A broad range of other biological products designed for the treatment of chronic and critical illnesses.

Small Molecules

Certain active pharmaceutical ingredients and finished dosage forms for various therapeutic applications.